Strength Training and Resveratrol
Part of paid clinical trials in Lubbock, Texas.
- Sponsor
- Texas Tech University
- Study ID
- NCT06585865
- Status
- Recruiting
Conditions
- Anabolic Resistance
- Sarcopenia
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Resistance training — BEHAVIORALAfter pre-testing, participants will perform full-body strength training three times per week for two 6-week blocks. The acute program variables (sets, repetitions, training frequency) will follow a non-linear periodized, progressive design consisting of muti-joint and single-joint exercises. Exercise stress will be varied by using different exercises and loads. The two training blocks will be separated by a mid-intervention testing week, allowing for the study team to monitor participants' progress, communicate progress to participants to promote adherence, and adjust target loads as appropriate for the second half of the intervention. An additional testing week will follow the second 6-week block.
- Resveratrol 500 mg oral once daily. — DIETARY_SUPPLEMENTParticipants will be randomized to consume resveratrol (500 mg) daily for 14 weeks (two 6-week blocks of resistance training \[supervised, full-body, 3 days/week\] + one testing week \[3 days\] following each block) after the pre-testing period. Participants will be provided with 7 days' worth of supplements at a time in pre-filled pill boxes. Pill boxes will be refilled weekly and adherence monitored.
- Placebo — DIETARY_SUPPLEMENTParticipants will be randomized to consume placebo capsules (cellulose, visually identical to resveratrol capsules) daily for 14 weeks (two 6-week blocks of resistance training \[supervised, full-body, 3 days/week\] + one testing week \[3 days\] following each block) after the pre-testing period. Participants will be provided with 7 days' worth of supplements at a time in pre-filled pill boxes. Pill boxes will be refilled weekly and adherence monitored.
Study Details
The main goal of this study is to find out if supplementing with resveratrol improves skeletal muscle adaptations to strengthening exercise (resistance training or strength training) in adults age 60+, and to determine whether circulating vehicles of inter-organ communication (extracellular vesicles) and their cargo might help explain those responses. The investigators will also examine whether resveratrol supplementation improves blood vessel function and cognitive function (brain health) in response to strength training.
Key Dates
- Start date
- Jun 13, 2025
- Status verified
- Jun 2025
- Primary completion
- Jul 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 36 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Resveratrol (RSV) groupParticipants will be randomized to consume resveratrol (500 mg) daily for 14 weeks (two 6-week blocks of resistance training \[supervised, full-body, 3 days/week\] + one testing week \[3 days\] following each block) after the pre-testing period. Participants will be provided with 7 days' worth of supplements at a time in pre-filled pill boxes. Pill boxes will be refilled weekly and adherence monitored.
- Placebo Comparator: PlaceboParticipants will be randomized to consume placebo capsules (cellulose, visually identical to resveratrol capsules) daily for 14 weeks (two 6-week blocks of resistance training \[supervised, full-body, 3 days/week\] + one testing week \[3 days\] following each block) after the pre-testing period. Participants will be provided with 7 days' worth of supplements at a time in pre-filled pill boxes. Pill boxes will be refilled weekly and adherence monitored.
Primary Outcome Measure
Circulating extracellular vesicle microRNA profile [ Time Frame: During pre-, mid-, and post-testing (each separated by about 6 weeks) ]
Central Contacts
- Danielle E Levitt, PhD806-834-1830
- Jacob A Mota, PhD806-834-8772
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Department of Kinesiology & Sport Management, Texas Tech University | Lubbock | Texas | 79409 |
Find similar trials in Lubbock, TX
Related Studies
- MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Mitigate ICU Acquired Weakness in Medical ICU PatientsRecruiting · Health Discovery Labs · Rochester, Minnesota
- Sarcopenia in Chronic Kidney Disease (CKD) PatientsEARLY_PHASE1 · Not Yet Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal CancerRecruiting · Wake Forest University Health Sciences · Millville, Delaware
- Identifying Modifiable PAtient Centered Therapeutics (IMPACT) FrailtyRecruiting · University of California, Los Angeles · Los Angeles, California